Introduction: severe sepsis and drotrecogin alfa (... [Crit Care. 2007] - PubMed

Save items

loading

Related citations in PubMed

Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. [Pediatrics. 2004]
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.
Barton P, Kalil AC, Nadel S, Goldstein B, Okhuysen-Cawley R, Brilli RJ, Takano JS, Martin LD, Quint P, Yeh TS, et al. Pediatrics. 2004 Jan; 113(1 Pt 1):7-17.
Review Drotrecogin alfa (activated) in the treatment of severe sepsis. [Expert Rev Anti Infect Ther. 2...]
Review Drotrecogin alfa (activated) in the treatment of severe sepsis.
Vincent JL. Expert Rev Anti Infect Ther. 2006 Aug; 4(4):537-47.
Review Clinical trials in severe sepsis with drotrecogin alfa (activated). [Crit Care. 2007]
Review Clinical trials in severe sepsis with drotrecogin alfa (activated).
Laterre PF. Crit Care. 2007; 11 Suppl 5:S5.
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. [Crit Care Med. 2005]
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment.
Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, et al. Crit Care Med. 2005 Oct; 33(10):2266-77.
Review The development of drotrecogin alfa (activated) for the treatment of severe sepsis. [Int J Artif Organs. 2004]
Review The development of drotrecogin alfa (activated) for the treatment of severe sepsis.
Macias WL, Yan SB, Grinnell BW. Int J Artif Organs. 2004 May; 27(5):360-70.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Introduction: severe sepsis and drotrecogin alfa (activated).
Introduction: severe sepsis and drotrecogin alfa (activated).
Crit Care. 2007 ;11 Suppl 5:S1.

PubMed
No association of high-risk human papillomavirus with esophageal squamous cell c...
No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction.
Dis Esophagus. 2008 ;21(2):114-7.

PubMed
Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosig...
Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.
Diabetes Obes Metab. 2008 Mar ;10(3):251-63.

PubMed
Gene silencing in plants using artificial microRNAs and other small RNAs.
Gene silencing in plants using artificial microRNAs and other small RNAs.
Plant J. 2008 Feb ;53(4):674-90.

PubMed
Gut microflora: a new target for therapeutic approaches in inflammatory bowel di...
Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
Expert Opin Ther Targets. 2008 Mar ;12(3):301-12.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Introduction: severe sepsis and drotrecogin alfa (activated).

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information